Valiant Laboratories (BOM:543998) EV-to-EBITDA : 648.68 (As of Jun. 02, 2025)

Valiant Laboratories EV-to-EBITDA Chart

Valiant Laboratories Quarterly Data
	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBITDA	Get a 7-Day Free Trial								443.93	-132.78	-54.93	-172.59	502.25

Competitive Comparison of Valiant Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Valiant Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valiant Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valiant Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Valiant Laboratories's EV-to-EBITDA falls into.

Valiant Laboratories EV-to-EBITDA Calculation

Valiant Laboratories's EV-to-EBITDA for today is calculated as:

Valiant Laboratories's current Enterprise Value is ₹4,900 Mil.
Valiant Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valiant Laboratories  (BOM:543998) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Valiant Laboratories's PE Ratio (TTM) for today is calculated as:

Valiant Laboratories's share price for today is ₹102.26.
Valiant Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.510.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Valiant Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description